Imunon, Inc. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
Imunon, Inc. (IMNN) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $7.46 million as of 2024-03-31, per its 10-Q filed 2024-05-13.
Financial Statements › Notes
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2025-02-27
- 2024-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $7.46M.
- 2023-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $9.86M.
- 2023-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $6.49M.
- 2023-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $17.40M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2024-03-31 | $7.46M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $9.86M 10-K · filed 2025-02-27 |
| 2023-09-30 | $6.49M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $17.40M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $20.78M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $21.25M 10-K · filed 2024-03-28 |
| 2022-09-30 | $10.41M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $15.37M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $12.94M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $29.80M 10-K · filed 2023-03-30 |
| 2021-09-30 | $28.86M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $31.92M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $15.00M 10-Q · filed 2021-05-14 |
| 2020-06-30 | $2.79M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $9.89M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $7.99M 10-K · filed 2021-03-19 |
| 2019-09-30 | $10.29M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $15.70M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $20.17M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $14.26M 10-K · filed 2020-03-25 |
| 2018-09-30 | $18.58M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $13.44M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $18.41M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $12.72M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |